Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve

Pediatric Blood and Cancer

Volumn 52, Issue 2, 2009, Pages 218-222

  Chantada, Guillermo L ^a   Guitter, Myriam R ^a   Fandiño, Adriana C ^a   Raslawski, Elsa C ^a   De Davila, Maria T G ^a   Vaiani, Elisa ^a   Scopinaro, Marcelo J ^a  

^a HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

Author keywords

Chemotherapy; Optic nerve involvement; Pathology; Radiotherapy; Retinoblastoma; Surgery

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; IDARUBICIN; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER STAGING; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENUCLEATION; EVENT FREE SURVIVAL; FEMALE; HUMAN; INFANT; MALE; MULTIPLE CYCLE TREATMENT; OPTIC NERVE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINOBLASTOMA; TREATMENT OUTCOME; ADOLESCENT; ADULT; CLINICAL TRIAL; COMPARATIVE STUDY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROSPECTIVE STUDY; RADIOTHERAPY; RECURRENT DISEASE; REMISSION; SECOND CANCER;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EYE ENUCLEATION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; OPTIC NERVE; PROSPECTIVE STUDIES; RADIOTHERAPY; RECURRENCE; REMISSION INDUCTION; RETINOBLASTOMA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 59449097033     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21735     Document Type: Article

References (26)

1. Magramm I, Abramson DH, Ellsworth RM. Optic nerve involvement in retinoblastoma. Ophthalmology 1989;96:217-222.
2. Honavar SG, Singh AD, Shields CL, et al. Postenucleation adjuvant therapy in high-risk retinoblastoma. Arch Ophthalmol 2002;120:923-931.
3. MacKay CJ, Abramson DH, Ellsworth RM. Metastatic patterns of retinoblastoma. Arch Ophthalmol 1984;102:391-396.
4. Antoneli CB, Steinhorst F, de Cassia Braga Ribeiro K, et al. Extraocular retinoblastoma: A 13-year experience. Cancer 2003;98:1292-1298.
5. Messmer EP, Heinrich T, Hopping W, et al. Risk factors for metastases in patients with retinoblastoma. Ophthalmology 1991;98:136-141.
6. Kopelman JE, McLean IW, Rosenberg SH. Multivariate analysis of risk factors for metastasis in retinoblastoma treated by enucleation. Ophthalmology 1987;94:371-377.
7. Howarth C, Meyer D, Hustu HO, et al. Stage-related combined modality treatment of retinoblastoma. Results of a prospective study. Cancer 1980;45:851-858.
8. Brisse HJ, Guesmi M, Aerts I, et al. Relevance of CT and MRI in retinoblastoma for the diagnosis of postlaminar invasion with normal-size optic nerve: A retrospective study of 150 patients with histological comparison. Pediatr Radiol 2007;37:649-656.
9. Zelter M, Damel A, Gonzalez G, et al. A prospective study on the treatment of retinoblastoma in 72 patients. Cancer 1991;68:1685-1690.
10. Chantada GL, Dunkel IJ, de Davila MT, et al. Retinoblastoma patients with high risk ocular pathological features: Who needs adjuvant therapy? Br J Ophthalmol 2004;88:1069-1073.
11. Khelfaoui F, Validire P, Auperin A, et al. Histopathologic risk factors in retinoblastoma: A retrospective study of 172 patients treated in a single institution. Cancer 1996;77:1206-1213.
12. Schvartzman E, Chantada G, Fandino A, et al. Results of a stage-based protocol for the treatment of retinoblastoma. J Clin Oncol 1996;14:1532-1536.
13. Chantada G, Fandino A, Davila MT, et al. Results of a prospective study for the treatment of retinoblastoma. Cancer 2004;100:834-842.
14. Chantada GL, Casco F, Fandino AC, et al. Outcome of patients with retinoblastoma and postlaminar optic nerve invasion. Ophthalmology 2007;114:2083-2089.
15. Chantada GL, Rossi J, Casco F, et al. An aggressive bone marrow evaluation including immunocytology with GD2 for advanced retinoblastoma. J Pediatr Hematol Oncol 2006;28:369-373.
16. Chantada G, Doz F, Antoneli CB, et al. A proposal for an international retinoblastoma staging system. Pediatr Blood Cancer 2006;47:801-805.
17. Chantada GL, Fandino A, Mato G, et al. Phase II window of idarubicin in children with extraocular retinoblastoma. J Clin Oncol 1999;17:1847-1850.
18. Gombos DS, Hungerford J, Abramson DH, et al. Secondary acute myelogenous leukemia in patients with retinoblastoma: Is chemotherapy a factor? Ophthalmology 2007;114:1378-1383.
19. Bellaton E, Bertozzi AI, Behar C, et al. Neoadjuvant chemotherapy for extensive unilateral retinoblastoma. Br J Ophthalmol 2003;87:327-329.
20. Abramson DH, Ellsworth RM. The surgical management of retinoblastoma. Ophthalmic Surg 1980;11:596-598.
21. Abramson DH, Schefler AC, Almeida D, et al. Optic nerve tissue shrinkage during pathologic processing after enucleation for retinoblastoma. Arch Ophthalmol 2003;121:73-75.
22. Mustafa MM, Jamshed A, Khafaga Y, et al. Adjuvant chemotherapy with vincristine, doxorubicin, and cyclophosphamide in the treatment of postenucleation high risk retinoblastoma. J Pediatr Hematol Oncol 1999;21:364-369.
23. Zelter M, Gonzalez G, Schwartz L, et al. Treatment of retinoblastoma. Results obtained from a prospective study of 51 patients. Cancer 1988;61:153-160.
24. Antoneli CB, Ribeiro KB, Rodriguez-Galindo C, et al. The addition of ifosfamide/etoposide to cisplatin/teniposide improves the survival of children with retinoblastoma and orbital involvement. J Pediatr Hematol Oncol 2007;29:700-704.
25. Stannard C, Sealy R, Hering E, et al. Postenucleation orbits in retinoblastoma: Treatment with 125I brachytherapy. Int J Radiat Oncol Biol Phys 2002;54:1446-1454.
26. Darzy KH, Shalet SM. Hypopituitarism after cranial irradiation. J Endocrinol Invest 2005;28:78-87.